Education
About Us
Working with TipRanks
Follow Us
Anatara Lifesciences Ltd (AU:ANR)
:ANR
RESEARCH TOOLSreports
ANR Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.07
Previous CloseN/A
Volume35.84K
Average Volume (3M)1.06M
Market Cap
AU$1.49M
Enterprise ValueAU$6.62M
Total Cash (Recent Filing)AU$1.50M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta0.01
Next Earnings
Aug 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding213,383,730
10 Day Avg. Volume3,048,202
30 Day Avg. Volume1,062,709
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)9.82
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Anatara Lifesciences Ltd News
PremiumCompany Announcements
Anatara Lifesciences Advances GaRP-IBS Trial and Anti-Obesity Project
PremiumCompany Announcements
Anatara Lifesciences Initiates Trading Halt Ahead of Key IBS Trial Update
PremiumCompany Announcements
Anatara Lifesciences Announces Board Changes Amid Strategic Renewal
PremiumCompany Announcements
Anatara Lifesciences Reports Revenue Surge Amid Rising Losses
PremiumCompany Announcements
Anatara Lifesciences Advances IBS Trial and Anti-Obesity Project
PremiumCompany Announcements
Anatara Lifesciences Advances GaRP-IBS Trial and Expands Portfolio
PremiumCompany Announcements
Anatara Lifesciences Issues New Unlisted Options---
Options Prices
Currently, No data available
---
Ownership Overview
3.67% Insiders
―
Mutual Funds
― Other Institutional Investors
96.33% Public Companies and
Individual Investors
ANR FAQ
What was Anatara Lifesciences Ltd’s price range in the past 12 months?
Anatara Lifesciences Ltd lowest share price was AU$0.01 and its highest was AU$0.07 in the past 12 months.
What is Anatara Lifesciences Ltd’s market cap?
Anatara Lifesciences Ltd’s market cap is AU$1.49M.
When is Anatara Lifesciences Ltd’s upcoming earnings report date?
Anatara Lifesciences Ltd’s upcoming earnings report date is Aug 20, 2025 which is in 139 days.
How were Anatara Lifesciences Ltd’s earnings last quarter?
Anatara Lifesciences Ltd released its earnings results on Feb 24, 2025. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
Is Anatara Lifesciences Ltd overvalued?
According to Wall Street analysts Anatara Lifesciences Ltd’s price is currently Overvalued.
Does Anatara Lifesciences Ltd pay dividends?
Anatara Lifesciences Ltd does not currently pay dividends.
What is Anatara Lifesciences Ltd’s EPS estimate?
Anatara Lifesciences Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anatara Lifesciences Ltd have?
Anatara Lifesciences Ltd has 213,383,730 shares outstanding.
What happened to Anatara Lifesciences Ltd’s price movement after its last earnings report?
Anatara Lifesciences Ltd reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Anatara Lifesciences Ltd?
Currently, no hedge funds are holding shares in AU:ANR
---
Anatara Lifesciences Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:ANR Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Bought Shares
Worth AU$30.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
-64.51%
12-Months-Change
Fundamentals
Return on Equity
-147.32%
Trailing 12-Months
Asset Growth
23.06%
Trailing 12-Months
Company Description
Anatara Lifesciences Ltd
Anatara Lifesciences Limited engages in the research, development, and commercializing of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming, a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditions, such as irritable bowel syndrome and inflammatory bowel disease; and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets; BONIFF, a revised formulation to dry feed for piglets after weaning; and ANR-pf, a proprietary formulation for poultry water. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.
---
Technical Analysis
Cynata Therapeutics Limited
―
Imugene Limited
―
Patrys Limited
―
Recce Pharmaceuticals Ltd.
―
---